Video Laryngoscopy Versus Direct Laryngoscopy for Nasotracheal Intubation
Launched by MEDICAL UNIVERSITY OF VIENNA · Jun 4, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different methods for inserting a breathing tube (called nasotracheal intubation) in young children who have congenital heart disease and need heart surgery. Specifically, the study compares the success rates of using a video laryngoscope, which has a camera to help see the airway, versus a direct laryngoscope, which is the traditional method that uses a handheld tool to look down the throat. The goal is to find out which method helps doctors successfully insert the tube on the first try.
To be eligible for this trial, participants must be less than 1 year old, have congenital heart disease, and be scheduled for cardiac surgery that requires them to stay in the intensive care unit afterward. The study will involve about 60 infants and neonates, and those who choose to participate will be randomly assigned to one of the two methods. Parents can expect their child to receive standard care during the procedure, and the study aims to improve the way anesthesia is administered to young patients in the future.
Gender
ALL
Eligibility criteria
- • Inclusion criteria.
- • Age less than 1 year
- • Congenital heart disease
- • Scheduled for cardiac surgery
- • Planned postoperative ICU stay
- • Exclusion criteria
- • Nostrils not suitable for nasotracheal intubation
- • Bleeding during dilation of nostrils
About Medical University Of Vienna
The Medical University of Vienna is a leading research institution dedicated to advancing healthcare through innovative clinical research and education. Renowned for its commitment to excellence in medical science, the university fosters interdisciplinary collaboration among researchers, clinicians, and academic professionals. Its clinical trials encompass a wide range of medical disciplines, aiming to develop cutting-edge therapies and improve patient outcomes. With state-of-the-art facilities and a strong emphasis on ethical standards, the Medical University of Vienna is at the forefront of transforming scientific discoveries into practical applications that enhance global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vienna, , Austria
Patients applied
Trial Officials
Eva M Base, MD
Principal Investigator
Medical University of Vienna
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported